Literature DB >> 9205849

Optimal treatment of heart failure in the elderly.

R Doughty1, V Andersen, N Sharpe.   

Abstract

Heart failure is a common condition in the elderly and one that is likely to become more prevalent as the population ages. Many drugs have been developed for the treatment of heart failure, but because clinical trials of these agents have often not included elderly patients their results need to be extrapolated from younger to older patients. Age-related physiological changes that affect how the available treatments are used occur in many organ systems. Effective management strategies can be implemented in elderly patients as well as in younger age groups, and these can improve both functional status and quality of life as well as reducing hospital admission and improving survival. This article reviews the physiological changes that occur in the elderly and the treatment approach that can be taken in elderly patients with heart failure.

Entities:  

Mesh:

Year:  1997        PMID: 9205849     DOI: 10.2165/00002512-199710060-00004

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  27 in total

Review 1.  Is aspirin safe for patients with heart failure?

Authors:  J G Cleland; C J Bulpitt; R H Falk; I N Findlay; C M Oakley; G Murray; P A Poole-Wilson; C R Prentice; G C Sutton
Journal:  Br Heart J       Date:  1995-09

2.  Heart failure. A decision analytic analysis of New Zealand data using the published results of the SOLVD Treatment Trial. Studies of Left Ventricular Dysfunction.

Authors:  W G Scott; H M Scott
Journal:  Pharmacoeconomics       Date:  1996-02       Impact factor: 4.981

3.  Diastolic dysfunction in elderly patients with congestive heart failure.

Authors:  W F Wong; S Gold; O Fukuyama; P L Blanchette
Journal:  Am J Cardiol       Date:  1989-06-15       Impact factor: 2.778

4.  Epidemiology of heart failure.

Authors:  W B Kannel; A J Belanger
Journal:  Am Heart J       Date:  1991-03       Impact factor: 4.749

5.  Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group.

Authors:  M Packer; C M O'Connor; J K Ghali; M L Pressler; P E Carson; R N Belkin; A B Miller; G W Neuberg; D Frid; J H Wertheimer; A B Cropp; D L DeMets
Journal:  N Engl J Med       Date:  1996-10-10       Impact factor: 91.245

Review 6.  Physiological changes due to age. Implications for cardiovascular drug therapy.

Authors:  I Stolarek; P J Scott; F I Caird
Journal:  Drugs Aging       Date:  1991 Nov-Dec       Impact factor: 3.923

Review 7.  Inhibition of the renin-angiotensin-aldosterone system in heart failure: new insights from basic clinical research.

Authors:  J G Cleland; K Morgan
Journal:  Curr Opin Cardiol       Date:  1996-05       Impact factor: 2.161

8.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

9.  Prevalence of heart failure in three general practices in north west London.

Authors:  J Parameshwar; M M Shackell; A Richardson; P A Poole-Wilson; G C Sutton
Journal:  Br J Gen Pract       Date:  1992-07       Impact factor: 5.386

Review 10.  Diuretics and potassium in the elderly.

Authors:  D W Levy; M Lye
Journal:  J R Coll Physicians Lond       Date:  1987-04
View more
  1 in total

Review 1.  Calcium sensitising agents in heart failure.

Authors:  L Mathew; S D Katz
Journal:  Drugs Aging       Date:  1998-03       Impact factor: 3.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.